Diabetes, Vol 46, Issue 6 958-967, Copyright © 1997 by American Diabetes Association

ARTICLES

Novel insulinoma cell lines produced by iterative engineering of GLUT2, glucokinase, and human insulin expression

SA Clark, C Quaade, H Constandy, P Hansen, P Halban, S Ferber, CB Newgard and K Normington
BetaGene, Inc., Dallas, TX 75207, USA.

Cellular engineering studies in our group are directed at creating insulin-secreting cell lines that simulate the performance of the normal islet beta-cell. The strategy described in this article involves the stepwise stable introduction of genes relevant to beta-cell performance into the RIN 1046-38 insulinoma cell line, a process that we term "iterative engineering." RIN cells stably engineered to contain multiple copies of the human insulin gene exhibit a large increase in insulin content, such that they approach the content of human islets assayed in parallel. Analysis by high-performance liquid chromatography demonstrates that these engineered cell lines process human proinsulin to mature insulin with high efficiency. Cell lines that are further engineered to express the GLUT2 and glucokinase genes demonstrate stable expression of the three transgenes for the full lifetime of the lines produced to date (6 months to 1 year in continuous culture). Transplantation of the engineered cell lines into nude rats reveals that stably integrated genes are expressed at constant levels in the in vivo environment over the full duration of experiments performed (48 days). Several endogenous genes expressed in normal beta-cells, including rat insulin, amylin, sulfonylurea receptor, and glucokinase, are stably expressed in the insulinoma lines during these in vivo studies. Endogenous GLUT2 expression, in contrast, is rapidly extinguished during in vivo passage. The loss of GLUT2 is overcome in engineered cell ines in which transporter expression is provided by a stably transfected transgene. These results suggest that a potential advantage of the iterative engineering approach may be to preserve stability of function and phenotype, particularly in the in vivo setting.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. Herrington, M. Sanchez, D. Wunderler, L. Yan, R. M Bugianesi, I. E Dick, S. A Clark, R. M Brochu, B. T Priest, M. G Kohler, et al. Biophysical and pharmacological properties of the voltage-gated potassium current of human pancreatic {beta}-cells J. Physiol., August 15, 2005; 567(1): 159 - 175. [Abstract] [Full Text] [PDF]

				V. V. Tran, G. Chen, C. B. Newgard, and H. E. Hohmeier Discrete and Complementary Mechanisms of Protection of {beta}-Cells Against Cytokine-Induced and Oxidative Damage Achieved by bcl-2 Overexpression and a Cytokine Selection Strategy Diabetes, June 1, 2003; 52(6): 1423 - 1432. [Abstract] [Full Text] [PDF]

				A. Calabrese, M. Zhang, V. Serre-Beinier, D. Caton, C. Mas, L. S. Satin, and P. Meda Connexin 36 Controls Synchronization of Ca2+ Oscillations and Insulin Secretion in MIN6 Cells Diabetes, February 1, 2003; 52(2): 417 - 424. [Abstract] [Full Text] [PDF]

				D. Dufayet de la Tour, T. Halvorsen, C. Demeterco, B. Tyrberg, P. Itkin-Ansari, M. Loy, S.-J. Yoo, E. Hao, S. Bossie, and F. Levine {beta}-Cell Differentiation from a Human Pancreatic Cell Line in Vitro and in Vivo Mol. Endocrinol., March 1, 2001; 15(3): 476 - 483. [Abstract] [Full Text]

				J. C. JIMÉNEZ-CHILLARÓN, C. B. NEWGARD, and A. M. GÓMEZ-FOIX Increased glucose disposal induced by adenovirus-mediated transfer of glucokinase to skeletal muscle in vivo FASEB J, December 1, 1999; 13(15): 2153 - 2160. [Abstract] [Full Text]

				Z. Ma, S. Ramanadham, M. Wohltmann, A. Bohrer, F.-F. Hsu, and J. Turk Studies of Insulin Secretory Responses and of Arachidonic Acid Incorporation into Phospholipids of Stably Transfected Insulinoma Cells That Overexpress Group VIA Phospholipase A2 (iPLA2beta ) Indicate a Signaling Rather Than a Housekeeping Role for iPLA2beta J. Biol. Chem., April 13, 2001; 276(16): 13198 - 13208. [Abstract] [Full Text] [PDF]

				R. N. Faradji, E. Havari, Q. Chen, J. Gray, K. Tornheim, B. E. Corkey, R. C. Mulligan, and M. A. Lipes Glucose-induced Toxicity in Insulin-producing Pituitary Cells That Coexpress GLUT2 and Glucokinase. IMPLICATIONS FOR METABOLIC ENGINEERING J. Biol. Chem., September 21, 2001; 276(39): 36695 - 36702. [Abstract] [Full Text] [PDF]